Stay updated with breaking news from Lpcn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Research analysts at StockNews.com began coverage on shares of Lipocine (NASDAQ:LPCN – Get Free Report) in a research note issued to investors on Thursday. The brokerage set a “buy” rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance Shares of NASDAQ:LPCN opened at $5.09 on Thursday. Lipocine has a 52 week low of $3.30 […]
StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a report issued on Wednesday. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Price Performance LPCN opened at $4.91 on Wednesday. The stock’s fifty day moving average is $4.65 and its 200-day moving average is $5.97. Lipocine has […]
StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research report sent to investors on Tuesday morning. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Price Performance Shares of Lipocine stock opened at $4.24 on Tuesday. Lipocine has a 1 year low of $3.30 and a […]
StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research report released on Monday. The firm issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance NASDAQ:LPCN opened at $4.42 on Monday. Lipocine has a 1 year low of $3.30 and a 1 year high of $14.28. The […]
StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research report report published on Monday morning. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Trading Down 2.9 % NASDAQ:LPCN opened at $4.29 on Monday. The firm has a market cap of $22.31 million, a P/E ratio […]